Physician profile
Robila Ashfaq
NPI 1609048396
$11,631.10
in general payments reported to CMS, 2019-2025
10 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.11 · 2021: $2,812 · 2022: $2,925 · 2023: $5,638 · 2024: $76.73 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,500 · Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,500.00 |
| Food and Beverage | $359.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11,268.19 | 2021-2023 | Nexplanon |
| Abbvie INC. | $151.01 | 2024-2025 | |
| Glaxosmithkline, LLC. | $66.68 | 2019-2024 | Rotarix, Shingrix |
| Pfizer INC. | $30.82 | 2024 | |
| Merck Sharp & Dohme LLC | $27.81 | 2019-2021 | |
| Hologic Sales and Service, LLC | $20.26 | 2021 | |
| Alkermes, INC. | $19.63 | 2021 | |
| Dexcom, INC. | $16.75 | 2022 | |
| Cipher Pharmaceuticals US LLC | $15.53 | 2025 | Spinosad, Natroba |
| Novo Nordisk INC | $14.42 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robila Ashfaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.